These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Interferon and the immunological system: cellular aspects]. Jemma C Recenti Prog Med; 1981 Jan; 70(1):25-45. PubMed ID: 6170098 [No Abstract] [Full Text] [Related]
4. The human interferon system. Berman B; Frankfort HM Int J Dermatol; 1982; 21(1):12-8. PubMed ID: 6174471 [No Abstract] [Full Text] [Related]
5. Enhancement by interferon of natural killer cell activity in mice. Senik A; Gresser I; Maury C; Gidlund M; Orn A; Wigzell H Cell Immunol; 1979 Apr; 44(1):186-200. PubMed ID: 313257 [No Abstract] [Full Text] [Related]
6. [Interferon--properties and action]. Zamorska I; Kozłowski M Wiad Lek; 1989 Oct 1-Nov 1; 42(19-21):1086-91. PubMed ID: 2517808 [TBL] [Abstract][Full Text] [Related]
7. Enhanced NK cell activity in mice injected with interferon and interferon inducers. Gidlund M; Orn A; Wigzell H; Senik A; Gresser I Nature; 1978 Jun; 273(5665):759-61. PubMed ID: 566386 [No Abstract] [Full Text] [Related]
8. Resistance to interferon of a human adenocarcinoma cell line, HEC-1, and its sensitivity to natural killer cell action. Chen HY; Sato T; Fuse A; Kuwata T; Content J J Gen Virol; 1981 Jan; 52(Pt 1):177-81. PubMed ID: 6167662 [TBL] [Abstract][Full Text] [Related]
10. [Endogenous opiate neuropeptides and the immune system]. Vasil'eva EV; Sukhikh GT; Vinogradov VA; Sura VV Ter Arkh; 1984; 56(10):120-5. PubMed ID: 6098041 [No Abstract] [Full Text] [Related]
11. Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes. Lee SH; Kelley S; Chiu H; Stebbing N Cancer Res; 1982 Apr; 42(4):1312-6. PubMed ID: 6174222 [TBL] [Abstract][Full Text] [Related]
12. [The induction of lymphokine-activated killer cells: increased cytotoxicity via long-term cultivation]. Hartwig M; Körner IJ; Malz W Arch Geschwulstforsch; 1989; 59(2):73-7. PubMed ID: 2785787 [TBL] [Abstract][Full Text] [Related]
13. Antiproliferative and antiviral activities of human leukocyte interferons. Evinger M; Rubinstein M; Pestka S Arch Biochem Biophys; 1981 Aug; 210(1):319-29. PubMed ID: 6170263 [No Abstract] [Full Text] [Related]
14. Effects of selenium in vitro on human T-lymphocyte functions and K-562 tumor cell growth. Watson RR; Moriguchi S; McRae B; Tobin L; Mayberry JC; Lucas D J Leukoc Biol; 1986 Apr; 39(4):447-56. PubMed ID: 2419467 [TBL] [Abstract][Full Text] [Related]
16. Lack of sensitivity to ouabain in natural killer activity. de Moraes VL; Olej B; de la Rocque L; Rumjanek VM FASEB J; 1989 Oct; 3(12):2425-9. PubMed ID: 2477295 [TBL] [Abstract][Full Text] [Related]
17. Effector cell sensitivity to sugar moieties. II. Inhibition by monosaccharides of interferon enhanced human natural killing. Ades EW; Hinson A J Clin Lab Immunol; 1983 Aug; 11(4):173-6. PubMed ID: 6199501 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of human natural killer cells by interferon requires RNA and protein synthesis. Bishop GA; Schwartz SA Clin Immunol Immunopathol; 1982 Dec; 25(3):374-85. PubMed ID: 6186424 [No Abstract] [Full Text] [Related]
19. Effect of various interferons on the spontaneous cytotoxicity exerted by lymphocytes from normal and tumor-bearing patients. Lucero MA; Fridman WH; Provost MA; Billardon C; Pouillart P; Dumont J; Falcoff E Cancer Res; 1981 Jan; 41(1):294-9. PubMed ID: 6160906 [TBL] [Abstract][Full Text] [Related]
20. Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon. Zarling JM; Eskra L; Borden EC; Horoszewicz J; Carter WA J Immunol; 1979 Jul; 123(1):63-70. PubMed ID: 286738 [No Abstract] [Full Text] [Related] [Next] [New Search]